ARTICLE | Financial News

Cancer microbiome play Evelo raises $35M

November 5, 2015 1:36 AM UTC

Evelo Therapeutics Inc. raised $35 million in an initial financing from sole investor Flagship Ventures. The cancer microbiome company has operated within the firm's Flagship VentureLabs incubator for two years.

Evelo's Oncobiotic therapeutics are bacteria that elicit an anti-tumor effect either in the tumor microenvironment or by activating immune cells against the tumor. Evelo has selected several undisclosed preclinical candidates to treat solid tumors. ...